Jianpi Yiqi Busui prescription alleviates myasthenia gravis by regulating Th17 through the TAK1/P38 MAPK/eIF-4E signaling pathway
Jianpi Yiqi Busui Prescription (JYBP), a traditional Chinese medicine (TCM) formula, is used in the treatment of myasthenia gravis (MG). However, its mechanisms of action still require further clarification. In this study, an experimental autoimmune myasthenia gravis (EAMG) rat model was establishe...
Saved in:
Main Authors: | Zhuming Chen, Jing Lu, Tianying Chang, Dongmei Zhang, Yibin Zhang, Miao Liu, Tong Wu, Peng Xv, Jian Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Association of Basic Medical Sciences of Federation of Bosnia and Herzegovina
2025-02-01
|
Series: | Biomolecules & Biomedicine |
Subjects: | |
Online Access: | https://bjbms.org/ojs/index.php/bjbms/article/view/11546 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Multiple Brain Abscesses in a Patient with Myasthenia Gravis – a Case Report
by: S. Radzevičiūtė, et al.
Published: (2023-12-01) -
The Association Between Myasthenia Gravis and Higher Extrathymic Cancer Risk
by: Mohamed Khateb, et al.
Published: (2025-01-01) -
Targeting NF-kappaB-inducing kinase shapes B-cell homeostasis in myasthenia gravis
by: Xiaoyu Huang, et al.
Published: (2025-01-01) -
Diurnal cognitive functioning in patients with myasthenia gravis with the role of chronotype and depression:
a pilot study
by: Monika Wiłkość-Dębczyńska, et al.
Published: (2024-07-01) -
Co-occurrence of Myasthenia Gravis and Multiple Sclerosis: A Case Report
by: G. Rynkevič, et al.
Published: (2024-02-01)